Author

Ikuko Omori

The University of TokyoORCID 0000-0002-8040-8764Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Ikuko Omori1 paper · National Cancer Center Research Institute

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Keisuke NakamuraiD· 1 shared Naru SatoiD· 1 shared Susumu GoyamaiD· 1 shared Toshio KitamuraiD· 1 shared Yutaka EnomotoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Keisuke NakamuraORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The CD112-TIGIT/PVRIG Axis Mediates NK Cell Evasion inDecitabine-Treated Acute Myeloid Leukemia Cells

Keisuke Nakamura, Ikuko Omori, Naru Sato, Susumu Goyama, Toshio Kitamura, Yutaka Enomoto

This study shows that decitabine treatment increases CD112 expression in AML cells, which reduces NK cell-mediated cytotoxicity through the CD112-TIGIT/PVRIG axis, suggesting a strategy to enhance antileukemic activity by blocking this axis.

bioRxiv · Sep 10, 2026 · PreprintCancer Biology